Show simple item record

dc.contributor.authorBoz, Bingol A.
dc.contributor.authorErkekol, Oner F.
dc.contributor.authorYildirim, Z.
dc.contributor.authorCilli, A.
dc.contributor.authorAydin, O.
dc.contributor.authorBuyukozturk, S.
dc.contributor.authorBakirtas, A.
dc.contributor.authorSapan, N.
dc.contributor.authorIsik, R.
dc.contributor.authorKarakaya, G.
dc.contributor.authorGorguner, M.
dc.contributor.authorKarakoc, G.
dc.contributor.authorAlpaydyn, Ozgen A.
dc.contributor.authorDursun, A.
dc.contributor.authorBavbek, S.
dc.contributor.authorMisirligil, Z.
dc.contributor.authorErdener, F.
dc.contributor.authorGemicioglu, B.
dc.contributor.authorBayrak, P.
dc.date.accessioned2021-03-03T11:59:48Z
dc.date.available2021-03-03T11:59:48Z
dc.identifier.citationDursun A., Bavbek S., Misirligil Z., Erdener F., Buyukozturk S., Aydin O., Gemicioglu B., Bayrak P., Erkekol O. F. , Yildirim Z., et al., "National safety data of post-marketing use of omalizumab in severe persistent asthma in Turkey", 30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Türkiye, 11 - 15 Haziran 2011, cilt.66, ss.675-676
dc.identifier.othervv_1032021
dc.identifier.otherav_2b40e9b8-c89b-4093-a201-563ac5205629
dc.identifier.urihttp://hdl.handle.net/20.500.12627/33828
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectALERJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectİmmünoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.titleNational safety data of post-marketing use of omalizumab in severe persistent asthma in Turkey
dc.typeBildiri
dc.contributor.departmentAtaturk Chest Diseases & Thoracic Surgery Education Research Hospital , ,
dc.identifier.volume66
dc.contributor.firstauthorID138265


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record